Host-dependent processes for HIV-1 replication make viable targets for drugs against which HIV-1 might not be able to devise protective mutations. In an attempt to more broadly identify host-dependent processes in HIV-1 replication will use retroviral mediated complementation cloning to deliver libraries of aptamer compounds (as Dominant Effectors (DEs) of intracellular signaling) as well as cDNAs into target cells, coupled with genetic selection schemes, to develop reagents that block HIV-1 entry and establishment processes. Selection systems will be those dependent upon NFAT activity and more broadly acting on HIV-1 post-entry processes. The aptamers and cDNAs will be used to pinpoint cellular processes that are required for HIV-1 establishment and replication. We propose that the dominant effector cloning systems discussed here, when applied to the screens to be described, will also provide reagents for further biological inquiry into NFAT and NF-kappaB signaling systems in T cells on which HIV-1 depends in T cells. The approach provides these aptamer as potential affinity reagents to isolate proteins with which they interact in pathways. This allows for characterization of these proteins, and the pathways in which they are involved, for potential use as therapeutic targets. In a sense, with such intracellularly expressed dominant effector aptamers, interference with a target protein that results in the desired phenotype validates that target protein as a potential therapeutic target for small-molecule drug discovery. An example of a host factor we have already defined as regulating key determinant of HIV-1 parasitism is the Nuclear Factor of Activated T cells. NFAT is a crucial contributor to the activation of HIV-1 transcriptional regulation through the HIV-1 enhancer, and an important component of the activation requirements for completion of reverse transcription in activated T cells. In normal CD4+ T cells NFAT activation of a cellular pathway is apparently critical for HIV-1. Since it is clear a pathway exists in T cells on which HIV-1 replication is dependent to an extent it is not dependent in other cell types we will further characterize the nature of the host target pathways that restrict HIV-1 replication. One downstream result of NFAT activation in T cells is direct HIV-1 activation through binding and interaction at the Rel binding sites of the core kappaB promoter in HIV-1. Therefore, another hypothesis to be explored is that NFAT and NF-kappaB can focus their transcriptional activities by coordinate binding at the HIV-1 enhancer motifs. The roles of these evolutionarily disparate Rel molecules in T cells will be dissected with regards to their activity upon the HIV-1 enhancer and promoter region.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI035304-06A1
Application #
6078535
Study Section
Special Emphasis Panel (ZRG1-AARR-1 (01))
Program Officer
Bridges, Sandra H
Project Start
1994-05-01
Project End
2005-01-31
Budget Start
2000-02-01
Budget End
2001-01-31
Support Year
6
Fiscal Year
2000
Total Cost
$281,731
Indirect Cost
Name
Stanford University
Department
Biology
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Angelo, Michael; Bendall, Sean C; Finck, Rachel et al. (2014) Multiplexed ion beam imaging of human breast tumors. Nat Med 20:436-42
Hammer, Mark M; Kotecha, Nikesh; Irish, Jonathan M et al. (2009) WebFlow: a software package for high-throughput analysis of flow cytometry data. Assay Drug Dev Technol 7:44-55
Krutzik, Peter O; Crane, Janelle M; Clutter, Matthew R et al. (2008) High-content single-cell drug screening with phosphospecific flow cytometry. Nat Chem Biol 4:132-42
Shachaf, Catherine M; Perez, Omar D; Youssef, Sawsan et al. (2007) Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. Blood 110:2674-84
Perez, Omar D; Mitchell, Dennis; Nolan, Garry P (2007) Differential role of ICAM ligands in determination of human memory T cell differentiation. BMC Immunol 8:2
Perez, Omar D; Nolan, Garry P (2006) Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol Rev 210:208-28
Krutzik, Peter O; Nolan, Garry P (2006) Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods 3:361-8
Wolkowicz, Roland; Jager, Gina C; Nolan, Garry P (2005) A random peptide library fused to CCR5 for selection of mimetopes expressed on the mammalian cell surface via retroviral vectors. J Biol Chem 280:15195-201
Krutzik, Peter O; Clutter, Matthew R; Nolan, Garry P (2005) Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry. J Immunol 175:2357-65
Krutzik, Peter O; Hale, Matthew B; Nolan, Garry P (2005) Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J Immunol 175:2366-73

Showing the most recent 10 out of 33 publications